Tekla Net Debt from 2010 to 2026

HQL Stock  USD 16.93  0.03  0.18%   
Tekla Life Net Debt yearly trend continues to be quite stable with very little volatility. The value of Net Debt is projected to decrease to about -91.2 K. Net Debt is the total debt of Tekla Life Sciences minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
1996-09-30
Previous Quarter
(1.00)
Current Value
-75.5 K
Quarterly Volatility
6.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Tekla Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 0.0 or Total Revenue of 104.3 M, as well as many indicators such as Price To Sales Ratio of 4.43, Dividend Yield of 0.13 or PTB Ratio of 0.82. Tekla financial statements analysis is a perfect complement when working with Tekla Life Valuation or Volatility modules.
  
Build AI portfolio with Tekla Stock
Check out the analysis of Tekla Life Correlation against competitors.
Historical Net Debt data for Tekla Life serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Tekla Life Sciences represents a compelling investment opportunity.

Latest Tekla Life's Net Debt Growth Pattern

Below is the plot of the Net Debt of Tekla Life Sciences over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Tekla Life's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tekla Life's overall financial position and show how it may be relating to other accounts over time.
Net Debt10 Years Trend
Very volatile
   Net Debt   
       Timeline  

Tekla Net Debt Regression Statistics

Arithmetic Mean241,234
Geometric Mean13,918
Coefficient Of Variation542.79
Mean Deviation688,298
Median(2,341)
Standard Deviation1,309,400
Sample Variance1.7T
Range6.1M
R-Value0.09
Mean Square Error1.8T
R-Squared0.01
Significance0.75
Slope22,087
Total Sum of Squares27.4T

Tekla Net Debt History

2026-91.2 K
2025-86.9 K
2024-75.5 K
2023 -1.0
2022 -477.0
202110.6 K
20201.3 M

Other Fundumenentals of Tekla Life Sciences

Tekla Life Net Debt component correlations

About Tekla Life Financial Statements

Tekla Life investors utilize fundamental indicators, such as Net Debt, to predict how Tekla Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Debt-86.9 K-91.2 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out the analysis of Tekla Life Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. Market participants price Tekla higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Tekla Life assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
2.594
Dividend Share
1.82
Earnings Share
2.79
Revenue Per Share
0.065
Quarterly Revenue Growth
(0.70)
Tekla Life Sciences's market price often diverges from its book value, the accounting figure shown on Tekla's balance sheet. Smart investors calculate Tekla Life's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Tekla Life's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.